THC Therapeutics, Inc. announced earnings results for the third quarter ended April 30, 2019. For the third quarter, the company announced operating loss was USD 18.693 million compared to USD 226,602 a year ago. Net loss was USD 22.131 million compared to USD 244,058 a year ago. Basic loss per share was USD 1.66 compared to USD 0.02 a year ago. For the nine months, operating loss was USD 19.368 million compared to USD 472,317 a year ago. Net loss was USD 26.113 million compared to USD 653,899 a year ago. Basic loss per share was USD 1.99 compared to USD 0.05 a year ago.